SARS-CoV-2 Seroassay Optimization and Performance in a Population with High Background Reactivity in Mali
John Woodford(National Institute of Allergy and Infectious Diseases), Patrick E. Duffy(National Institute of Allergy and Infectious Diseases), Halimatou Diawara(Unknown), Issaka Sagara(Inserm), Jonathan W. Yewdell(National Institute of Allergy and Infectious Diseases), Maryonne Snow-Smith(National Institute of Allergy and Infectious Diseases), Jennifer Kwan, Irfan Zaidi(National Institutes of Health), Peter D. Crompton(National Institutes of Health), Nada Alani(National Institute of Allergy and Infectious Diseases), Justin Doritchamou(National Institutes of Health), Oumar Attaher(University of Bamako), Dominic Esposito(Leidos (United States)), Jaroslav Hollý(National Institutes of Health), Mahamadoun Maiga(Université des Sciences, des Techniques et des Technologies de Bamako), Jonathan P. Renn(National Institute of Malaria Research), Kaitlyn Sadtler(National Institutes of Health), Boubacar Zan Traoré(Université des Sciences, des Techniques et des Technologies de Bamako), Alassane Dicko(University of Bamako), Ivan Košík(Government of the United States of America), Mamady Koné(Université des Sciences, des Techniques et des Technologies de Bamako), Amatigué Zéguimé
Cited by 7
Related Papers
XBP1, Downstream of Blimp-1, Expands the Secretory Apparatus and Other Organelles, and Increases Protein Synthesis in Plasma Cell Differentiation
|Immunity|2004|1k
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
|The Lancet|2024|345
Design, clinical translation and immunological response of biomaterials in regenerative medicine
|Nature Reviews Materials|2016|307
Novel serologic biomarkers provide accurate estimates of recent <i>Plasmodium falciparum</i> exposure for individuals and communities
|Proceedings of the National Academy of Sciences|2015|219